Opinion|Videos|November 26, 2024
Utilizing Antibiotics in Treatment of C Difficile
Author(s)Paul Feuerstadt, MD, FACG, AGAF
Key Takeaways
- Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI).
- New therapies like fecal microbiota transplantation (FMT) and monoclonal antibodies aim to restore healthy gut flora and provide targeted immune support.
The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections and a major risk factor for recurrence since they disrupt the protective gut microbiome, which led to the development of alternative therapies like fecal microbiota transplantation to restore microbial balance and prevent reinfection.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the role of antibiotics in the treatment of recurrent C difficile infections?
- Why was it necessary to develop new therapies beyond antibiotics?
Advertisement
Related to this article
Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on sequencing CKD therapies.
Insmed launches once-daily brensocatib in Japan, the country's only approved treatment for noncystic fibrosis bronchiectasis.
Advertisement
Advertisement
Trending on AJMC
1
Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives
2
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
3
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
4
It’s the Best of Times and Worst of Times for Cancer Care in Tampa
5